Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease. Biologicals

Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease. Biologicals

Malíčková K, Ďuricová D, Bortlík M, Hind’oš M, Machková N, Hrubá V, Lukáš M, Zima T, Lukáš M. Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease. Biologicals. 2016;44(1):33-6. doi: 10.1016/j.biologicals.2015.09.005. PMID: 26603635

Odkaz na článek

Další publikace

Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical
practice
přejít na článek
The efficacy and safety of budesonide MMX (Cortiment®) for long-term maintenance therapy of ulcerative colitis
The efficacy and safety of budesonide MMX (Cortiment®) for long-term maintenance therapy of ulcerative
colitis
přejít na článek
Pregnancy outcomes in women with IBD treated with biosimilar infliximab
Pregnancy outcomes in women with IBD treated with biosimilar
infliximab
přejít na článek
Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers
Fecal zonulin is elevated in Crohn’s disease and in cigarette
smokers
přejít na článek
Biosimilar infliximab in anti-TNF naïve IBD patients – 1-year clinical follow-up
Biosimilar infliximab in anti-TNF naïve IBD patients – 1-year clinical
follow-up
přejít na článek
Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical
practice
přejít na článek
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD
clinics
přejít na článek
Testování COVID-19-co bychom měli mít na paměti
Testování COVID-19-co bychom měli mít na
paměti
přejít na článek
Evaluation of Infliximab Therapy in Children with Crohn’s Disease Using Trough Levels Predictors
Evaluation of Infliximab Therapy in Children with Crohn’s Disease Using Trough Levels
Predictors
přejít na článek
The role of steroid hormones in the development of intrahepatic cholestasis of pregnancy
The role of steroid hormones in the development of intrahepatic cholestasis of
pregnancy
přejít na článek
Idiopatické střevní záněty a fertilita mužů
Idiopatické střevní záněty a fertilita
mužů
přejít na článek
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the intervention
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the
intervention
přejít na článek
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot project
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot
project
přejít na článek
P368 Tofacitinib induction efficiency and intracellular cytokine dynamics in ulcerative colitis: Results from clinical practice
P368 Tofacitinib induction efficiency and intracellular cytokine dynamics in ulcerative colitis: Results from clinical
practice
přejít na článek
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter
Observation
přejít na článek
The natural history of Crohn’s disease in children: a review of population-based studies
The natural history of Crohn’s disease in children: a review of population-based
studies
přejít na článek
Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies
Review article: the natural history of paediatric-onset ulcerative colitis in population-based
studies
přejít na článek
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD
study
přejít na článek
Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study
Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based
study
přejít na článek
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn’s Disease: A French Population-Based Study
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn’s Disease: A French Population-Based
Study
přejít na článek